Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
CoinDesk was acquired in an all-cash deal by Bullish, a crypto exchange run by former NYSE president Tom Farley.
McDonald’s bought out the 28% stake of its Chinese business owned by private equity giant Carlyle Group, just as it plans an expansion there.
The Transportation Security Administration is expecting to screen 30 million passengers between this past Sunday and November 28.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Hyundai will sell its cars directly on Amazon, marking the first major auto brand to list on the massive e-commerce platform.
Casgevy, a CRISPR gene-editing therapy, has been authorized by UK authorities to treat people with two blood diseases..
There aren’t a lot of people willing to drive or fly to Las Vegas to watch Formula 1 racers drive to survive.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Exxon announced plans to enter the lithium production game in 2027, effectively elbowing its way into the electric vehicle supply chain.
The neural interface market is full of startups vying to put technology into the human brain, but which will actually make brains a business?
AMC, the world’s largest movie theater chain, said Thursday that it filed to offer up to $350 million of stock.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.